Ovarian Cancer Archives

Gynecologic Cancer

Initiative Increased BRCA Testing in Ovarian Cancer Patients

By

Leah Lawrence

March 20, 2023

A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.

Not only may co-testing help detect more cases of invasive cervical cancer, but it also may lower ov

ONA Summit 2023

Characteristics, Treatment Options for Patients With Advanced Gynecologic Cancers

By

Joyce Pagan

March 19, 2023

A presentation at the 2023 ONA Summit reviewed diagnosis and treatment recommendations for uterine, ovarian, and endometrial cancers.

This fact sheet evaluates the data that suggest that aspirin can reduce the risk of liver and ovaria

Ovarian Cancer

Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin

March 14, 2023

Study shows that polygenic score does not modify the 13 percent reduction in ovarian cancer risk seen with aspirin.

Ovarian Cancer

Lifetime Ovulatory Years Linked to Epithelial Ovarian Cancer

March 10, 2023

Individual lifetime ovulatory years components associated with epithelial ovarian cancer apart from age at menarche.

Senior woman with cancer receiving therapy

Ovarian Cancer

Mirvetuximab Soravtansine Could Be New Standard Care for Platinum-Resistant Ovarian Cancer

By

Leah Lawrence

February 14, 2023

Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.

General Oncology

Ultra-Processed Food Linked to Increased Risk of Cancer and Death

By

Andrea S. Blevins Primeau, PhD, MBA

February 9, 2023

The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.

Breast Cancer

Evaluation of the Openness of Communication About Genetic Cancer Risk

By

Vicki Moore, PhD

February 2, 2023

An experimental analysis sought to determine the usefulness of a natural language processing approach to measure openness of communication about genetic risk within families with hereditary breast and ovarian cancer syndrome.

HPV testing alone every 3 years provides a high level of reassurance against cervical cancer.

Gynecologic Cancer

Risks of Sexual Dysfunction Higher for Survivors of Gynecologic Cancers

By

Vicki Moore, PhD

January 11, 2023

Researchers sought to determine whether survivors of gynecologic cancers had a higher risk of sexual dysfunction, compared with cancer-free women, and the risk factors for sexual dysfunction.